Related Experiment Video
Updated: Jul 11, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
[hsCRP protein in children and adolescents with diabetes type 1]
Barbara Głowińska-Olszewska1, Mirosława Urban, Jadwiga Peczyńska
1II Klinika Chorób Dzieci AM w Białymstoku. bglowinska@poczta.onet.pl
Insights
High-sensitivity C-reactive protein (hsCRP) levels are elevated in children with type 1 diabetes, particularly those with hypertension and obesity. These findings suggest a low-grade inflammatory state linked to metabolic syndrome in pediatric diabetes.
Area of Science:
- Pediatric Endocrinology
- Cardiovascular Risk Factors
- Inflammatory Markers
Context:
- Type 1 diabetes in children is associated with an early atherosclerotic process.
- Limited data exists on inflammatory markers in pediatric type 1 diabetes compared to adults.
- HsCRP is a novel marker for low-grade inflammation and early atherosclerosis.
Purpose:
- To assess high-sensitivity C-reactive protein (hsCRP) levels in children and adolescents with type 1 diabetes.
- To investigate the relationship between hsCRP levels and coexisting risk factors for atherosclerosis.
- To examine the association with microvascular complications in pediatric type 1 diabetes.
Summary:
- HsCRP levels were nearly significantly higher in the overall type 1 diabetes group compared to controls.
- Significantly elevated hsCRP was observed in diabetic children with hypertension and/or obesity.
- HsCRP correlated with systolic blood pressure, HbA1c, and triglyceride levels.
Impact:
- Elevated hsCRP in type 1 diabetes with hypertension/obesity indicates a low-grade inflammatory state.
- This highlights the presence of metabolic syndrome components in pediatric diabetes.
- Findings emphasize the need for monitoring inflammatory markers in at-risk pediatric populations.
Introduction:
HsCRP protein is known as a novel marker of low grade inflammatory state, which characterises an atherosclerotic process in its early stages. Contrary to a large amount of data on inflammatory markers in diabetes type 2 and metabolic syndrome in adults, little is known so far about the inflammatory process in diabetes type 1, especially in children. The aim of the study was to estimate the level of hsCRP protein in children and adolescents with diabetes type 1 depending on coexisting additional risk factors for atherosclerosis and microvascular complications.
Material And Methods:
127 children and adolescents with diabetes duration 6.7+/-3.3 years, aged 14.9+/-3.1, were studied. The control group consisted of 52 healthy children aged 14.9+/-2.8 years, matched acc. to gender. HsCRP level was assessed with use of immunoturbidymetric, latex augmented method (Tina-quant CRP (Latex) HS, Roche).
Results:
HsCRP in the whole study group was nearly significantly higher compared to control group: 0.17+/-0.2 vs. 0.078+/-0.1 mg/dl, p=0.072. In diabetic hypertensive children (n=38) we found significantly higher levels of hsCRP compared to controls (0.27+/-0.3 vs. 0.07 mg/dl, p=0.008) and compared to diabetic normotensive children (0.13+/-0.22 mg/dl; p=0.024). Diabetic obese patients (n=23) had significantly higer hsCRP compared to controls (0.24+/-0.3 vs. 0.07+/-0.1 mg/dl, p=0.04). In 14 studied diabetic children we found coexisting hypertension and obesity, and we found further increase in hsCRP level - 0.28+/-0.3 mg/dl. In diabetic children with microangiopathy hsCRP level was 0.22+/-0.2 mg/dl, and it was insignificantly higher compared to controls and to diabetic children without complications. Correlation analysis showed interrelations between hsCRP and systolic blood pressure (r=0.2; p=0.04) and HbA1c (r=0.25; p=0.015). In stepwise regression analysis hsCRP was related to systolic blood pressure, HbA1c and the triglycerides level (R=0.37; p=0.003).
Conclusions:
In children and adolescents with diabetes type 1 we proved significantly higher levels of hsCRP in case of a coexistence of hypertension and/or obesity. Elevated hsCRP in children with diabetes type 1 and hypertension and/or obesity reflects low grade inflammatory state in the course of metabolic syndrome.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type I Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Diabetic Retinopathy
